Director - Global PK/PD and Pharmacometrics
Eli Lilly and Company
Gary Mo, PhD, is currently a Director in Global PK/PD and Pharmacmetrics at Eli Lilly and Company. Previously he has also held similar positions at Pfizer and Metrum Research Group. He earned his PhD from McGill University and Postdoctoral training at SUNY University at Buffalo. Gary has worked extensively in the field of oncology providing Clinical Pharmacology and Pharmacometrics support, as well as supporting neuroscience and immunology programs. In addition to his work in industry, Gary is also involved in student training and mentoring.
Disclosure(s): No financial relationships to disclose